Marimed Capital Expenditures (CapEx) Growth & History (MRMD)
Marimed's capital expenditures (capex) was $1.2M for fiscal 2025.
View full Marimed company overviewMarimed annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.2M | −$10.8M | −90.24% |
| 2024 | 2024-12-31 | $12.0M | −$8.2M | −40.59% |
| 2023 | 2023-12-31 | $20.1M | $8.0M | +65.82% |
| 2022 | 2022-12-31 | $12.1M | −$5.7M | −32.08% |
| 2021 | 2021-12-31 | $17.9M | $13.2M | +281.29% |
| 2020 | 2020-12-31 | $4.7M | −$5.0M | −51.51% |
| 2019 | 2019-12-31 | $9.7M | $744,210 | +8.34% |
| 2018 | 2018-12-31 | $8.9M | −$12.1M | −57.45% |
| 2017 | 2017-12-31 | $21.0M | $17.6M | +523.52% |
| 2016 | 2016-12-31 | $3.4M | — | — |
| 2014 | 2014-12-31 | $2,666 | — | — |
Marimed quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $298,000 | −$11,000 | −3.56% |
| Q1 2026 | 2026-03-31 | $373,000 | $107,000 | +40.23% |
| Q4 2025 | 2025-12-31 | $33,000 | −$1.0M | −96.88% |
| Q3 2025 | 2025-09-30 | $559,000 | −$2.0M | −78.22% |
| Q2 2025 | 2025-06-30 | $309,000 | −$4.7M | −93.78% |
| Q1 2025 | 2025-03-31 | $266,000 | −$3.1M | −92.10% |
| Q4 2024 | 2024-12-31 | $1.1M | −$4.3M | −80.34% |
| Q3 2024 | 2024-09-30 | $2.6M | −$3.4M | −56.97% |
| Q2 2024 | 2024-06-30 | $5.0M | −$766,000 | −13.36% |
| Q1 2024 | 2024-03-31 | $3.4M | $316,000 | +10.35% |
| Q4 2023 | 2023-12-31 | $5.4M | $3.2M | +149.70% |
| Q3 2023 | 2023-09-30 | $6.0M | $3.8M | +179.82% |
| Q2 2023 | 2023-06-30 | $5.7M | $1.9M | +49.36% |
| Q1 2023 | 2023-03-31 | $3.1M | −$963,000 | −23.99% |
| Q4 2022 | 2022-12-31 | $2.2M | −$1.1M | −33.18% |
| Q3 2022 | 2022-09-30 | $2.1M | −$4.5M | −68.07% |
| Q2 2022 | 2022-06-30 | $3.8M | −$1.8M | −32.27% |
| Q1 2022 | 2022-03-31 | $4.0M | $1.7M | +73.96% |
| Q4 2021 | 2021-12-31 | $3.2M | $2.7M | +464.07% |
| Q3 2021 | 2021-09-30 | $6.7M | $5.3M | +378.21% |
| Q2 2021 | 2021-06-30 | $5.7M | $4.3M | +317.54% |
| Q1 2021 | 2021-03-31 | $2.3M | $944,831 | +69.31% |
| Q4 2020 | 2020-12-31 | $571,742 | −$2.4M | −80.47% |
| Q3 2020 | 2020-09-30 | $1.4M | −$1.4M | −50.08% |
| Q2 2020 | 2020-06-30 | $1.4M | −$1.1M | −43.62% |
| Q1 2020 | 2020-03-31 | $1.4M | −$175,245 | −11.39% |
| Q4 2019 | 2019-12-31 | $2.9M | $1.3M | +75.80% |
| Q3 2019 | 2019-09-30 | $2.8M | $1.2M | +75.17% |
| Q2 2019 | 2019-06-30 | $2.4M | −$2.0M | −44.89% |
| Q1 2019 | 2019-03-31 | $1.5M | $243,556 | +18.81% |
| Q4 2018 | 2018-12-31 | $1.7M | −$7.8M | −82.42% |
| Q3 2018 | 2018-09-30 | $1.6M | −$6.1M | −79.37% |
| Q2 2018 | 2018-06-30 | $4.4M | $2.4M | +122.95% |
| Q1 2018 | 2018-03-31 | $1.3M | −$511,797 | −28.33% |
| Q4 2017 | 2017-12-31 | $9.5M | — | — |
| Q3 2017 | 2017-09-30 | $7.7M | $5.9M | +319.19% |
| Q2 2017 | 2017-06-30 | $2.0M | — | — |
| Q1 2017 | 2017-03-31 | $1.8M | — | — |
| Q3 2016 | 2016-09-30 | $1.8M | — | — |
Marimed capital expenditures (capex) trends
Over the last five fiscal years, Marimed's capital expenditures (capex) decreased from $4.7M to $1.2M, a change of −$3.5M. The latest reported quarter, Q2 2026, shows $298,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marimed source filings ↗